HSCS – heartsciences inc. (US:NASDAQ)
Stock Stats
News
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
HeartSciences (HSCS) had its price target lowered by Ascendiant Capital Markets from $9.00 to $8.00. They now have a "buy" rating on the stock.
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
Form DEFA14A HeartSciences Inc.
Form DEF 14A HeartSciences Inc. For: Apr 30
Form 8-K HeartSciences Inc. For: Mar 16
Form 10-Q HeartSciences Inc. For: Jan 31
Form PRE 14A HeartSciences Inc. For: Mar 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.